October 1, 2016

We are proud to announce that we have received a contract from NIAID, the National Institute of Allergy and Infectious Diseases, a division of NIH, the National Institutes of Health. The contract enables us to develop a high-dose antibiotic Oral Dissolvable Strip (ODS)...

Please reload

Featured Posts

All of us at Oak Therapeutics are extremely proud to announce that we just concluded initial preclinical testing of our anti-malarial medication Artel...

OAK THERAPEUTICS SUCCESSFULLY CONCLUDES TRIAL OF MALARIA MEDICATION

June 17, 2015

1/1
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Oak Therapeutics, Inc., 2029 Becker Drive, Lawrence, KS 66047, United States, Tel. +1-913-346-0990, Email: office@oaktherapeutics.com